Menu
GeneBe

rs138955440

Variant summary

Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_017433.5(MYO3A):c.3352A>G(p.Thr1118Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000348 in 1,613,174 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00035 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00035 ( 4 hom. )

Consequence

MYO3A
NM_017433.5 missense

Scores

14

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:3

Conservation

PhyloP100: 1.78
Variant links:
Genes affected
MYO3A (HGNC:7601): (myosin IIIA) The protein encoded by this gene belongs to the myosin superfamily. Myosins are actin-dependent motor proteins and are categorized into conventional myosins (class II) and unconventional myosins (classes I and III through XV) based on their variable C-terminal cargo-binding domains. Class III myosins, such as this one, have a kinase domain N-terminal to the conserved N-terminal motor domains and are expressed in photoreceptors. The protein encoded by this gene plays an important role in hearing in humans. Three different recessive, loss of function mutations in the encoded protein have been shown to cause nonsyndromic progressive hearing loss. Expression of this gene is highly restricted, with the strongest expression in retina and cochlea. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.004783869).
BP6
Variant 10-26170493-A-G is Benign according to our data. Variant chr10-26170493-A-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 178467.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=1, Likely_benign=2, Benign=1}.
BS2
High Homozygotes in GnomAdExome at 2 SD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
MYO3ANM_017433.5 linkuse as main transcriptc.3352A>G p.Thr1118Ala missense_variant 29/35 ENST00000642920.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
MYO3AENST00000642920.2 linkuse as main transcriptc.3352A>G p.Thr1118Ala missense_variant 29/35 NM_017433.5 P1Q8NEV4-1
MYO3AENST00000543632.5 linkuse as main transcriptc.1777-41350A>G intron_variant 1
MYO3AENST00000647478.1 linkuse as main transcriptc.*1347A>G 3_prime_UTR_variant, NMD_transcript_variant 27/30

Frequencies

GnomAD3 genomes
AF:
0.000355
AC:
54
AN:
152226
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000523
Gnomad ASJ
AF:
0.0107
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000103
Gnomad OTH
AF:
0.000955
GnomAD3 exomes
AF:
0.000738
AC:
185
AN:
250732
Hom.:
2
AF XY:
0.000620
AC XY:
84
AN XY:
135534
show subpopulations
Gnomad AFR exome
AF:
0.0000616
Gnomad AMR exome
AF:
0.000580
Gnomad ASJ exome
AF:
0.0145
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000115
Gnomad OTH exome
AF:
0.000818
GnomAD4 exome
AF:
0.000348
AC:
508
AN:
1460948
Hom.:
4
Cov.:
30
AF XY:
0.000359
AC XY:
261
AN XY:
726796
show subpopulations
Gnomad4 AFR exome
AF:
0.0000598
Gnomad4 AMR exome
AF:
0.000492
Gnomad4 ASJ exome
AF:
0.0138
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000657
Gnomad4 OTH exome
AF:
0.000829
GnomAD4 genome
AF:
0.000355
AC:
54
AN:
152226
Hom.:
0
Cov.:
33
AF XY:
0.000323
AC XY:
24
AN XY:
74370
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.000523
Gnomad4 ASJ
AF:
0.0107
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000103
Gnomad4 OTH
AF:
0.000955
Alfa
AF:
0.000668
Hom.:
1
Bravo
AF:
0.000442
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.00
AC:
0
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000581
AC:
5
ExAC
AF:
0.000659
AC:
80
EpiCase
AF:
0.000382
EpiControl
AF:
0.000356

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:2
Likely benign, criteria provided, single submitterclinical testingGeneDxOct 28, 2022See Variant Classification Assertion Criteria. -
Benign, criteria provided, single submitterclinical testingInvitaeNov 16, 2023- -
Autosomal recessive nonsyndromic hearing loss 30 Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -
not specified Benign:1
Likely benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineJun 05, 2013Thr1118Ala in exon 29 of MYO3A: This variant is not expected to have clinical si gnificance due to a lack of conservation across species, including mammals. Furt hermore, this variant has been identified in 0.06% (5/8600) of European American chromosomes by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu /EVS/; dbSNP rs138955440). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.079
BayesDel_addAF
Benign
-0.49
T
BayesDel_noAF
Benign
-0.58
Cadd
Benign
4.6
Dann
Benign
0.10
DEOGEN2
Benign
0.037
T;T
Eigen
Benign
-0.96
Eigen_PC
Benign
-0.87
FATHMM_MKL
Benign
0.25
N
M_CAP
Benign
0.0085
T
MetaRNN
Benign
0.0048
T;T
MetaSVM
Benign
-0.98
T
MutationAssessor
Benign
1.4
L;L
MutationTaster
Benign
1.0
N;N
PrimateAI
Benign
0.39
T
Polyphen
0.0
B;B
Vest4
0.052
MVP
0.65
MPC
0.060
ClinPred
0.027
T
GERP RS
2.0
Varity_R
0.027
gMVP
0.078

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs138955440; hg19: chr10-26459422; API